(Q37478055)

20 August 2017

1 reference

title

Moving candidate vaccines into development from research: lessons from HIV. (English)

1 reference

20 August 2017

Mark Sullivan

1

1 reference

20 August 2017

publication date

12 May 2009

1 reference

Immunology & Cell Biology

20 August 2017

published in

1 reference

20 August 2017

volume

87

1 reference

20 August 2017

issue

5

1 reference

20 August 2017

page(s)

366-370

1 reference

An HIV vaccine--evolving concepts

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

Medicine. The need for a global HIV vaccine enterprise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

21 January 2018

Toward an AIDS vaccine

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

Correlates of immune protection and the development of a human immunodeficiency virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

SIV-specific T lymphocyte responses in PBMC and lymphoid tissues of SIV-infected pigtailed macaques during suppressive combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

Viremia control following antiretroviral treatment and therapeutic immunizationduring primary SIV251 infection of macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

Susan Allen: confronting HIV in Africa. Interview by Hema Bashyam

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

Skewed maturation of memory HIV-specific CD8 T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

Early Control of Highly Pathogenic Simian Immunodeficiency Virus/Human Immunodeficiency Virus Chimeric Virus Infections in Rhesus Monkeys Usually Results in Long-Lasting Asymptomatic Clinical Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

Pathogenesis of SIVmac infection in Chinese and Indian rhesus macaques: effects of splenectomy on virus burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

Safety assessment and dose selection for first-in-human clinical trials with immunomodulatory monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

Community perspectives on the ethical issues surrounding adolescent HIV vaccine trials in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

A model for community representation and participation in HIV prevention trials among women who engage in transactional sex in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

HIV vaccine failure prompts Merck to halt trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

Prospects for an AIDS vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

7 January 2021

HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

7 January 2021

Urgently needed: a filter for the HIV-1 vaccine pipeline

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

7 January 2021

Crippling HIV one mutation at a time

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

7 January 2021

Barriers to participating in an HIV vaccine trial: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.30

7 January 2021

Identifiers

DOI

10.1038/ICB.2009.30

1 reference

20 August 2017

1 reference